Also known as Applied LifeSciences & Systems and ALSS.
None yet. When a new project in the record names TARGAN as owner, partner or investor, it shows here.
Adds high-speed biodevices including vision-based chick gendering and an ocular vaccine spray; deal expected to close in Q3 2026 pending approvals.
